Purchase of disposable infusion, parenteral, enteral devices (NVC)

This tender for disposable medical supplies is generally well-structured, with clear documentation and a standard open procedure. However, it lacks specific evaluation criteria and details on financing, impacting its overall practicality and completeness.

The tender follows a standard open procedure compliant with EU directives. CPV code is provided, and there are no immediate indications of disputes or regulatory non-compliance. The deadline, while potentially short, is within a reasonable range for an open procedure.

The description of the procured items is clear. The tender notice and contract draft are available, providing a good basis for understanding the requirements. However, the absence of specified evaluation criteria is a notable gap.

Most basic information is present, including the organization, reference number, and contract duration. However, the estimated value is not disclosed, and financing information is absent, which are key components for a complete tender.

The tender is an open procedure, suggesting a fair process. Documents are accessible, and the value is intended to be disclosed (though currently missing). There are no apparent requirements tailored to specific companies, promoting a level playing field.

The tender is marked as 'E-Procurement', but the 'Checks' section indicates 'No e-submission', which is contradictory and needs clarification. The absence of financing information and a clear contract start date (implied by the submission deadline and duration) reduces practicality.

Key fields such as title, reference, organization, and dates are populated. There are no reported disputes or suspensions. The dates provided are logical within the context of a tender process.

There is no explicit mention of green procurement, social aspects, or innovation within the tender details. It is also not indicated as EU funded, which often comes with sustainability requirements.